ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 662192 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 662192; 2) Community: the network communities that were significantly associated with the response to NSC 662192; 3) Molecule: the relationships between components within communities and NSC 662192; 4) MDR: the compounds that were significantly associated with the NSC 662192.

NSC Compound Enrichment Correlation
NSC 668329 Null 0.00170676579199122 0.21567208
NSC 675004 Null 0.00170676579199122 0.094433298
NSC 677924 Benzo[a]quinolizinium, 7-bromo-6,7-dihydro- 2,4,7-triphenyl-, bromide 0.00170676579199122 0.23221976
NSC 678088 Null 0.00170676579199122 0.025585183
NSC 709437 Null 0.00170676579199122 0.45228318
NSC 733397 1-alpha-methyl-8-methoxy-5-bromo-6,7,-methylenedioxy-1-(6,7, -dimethoxy-3-phthalidyl)-1,2,3,4-tetrahydroisoquinoline 0.00170676579199122 0.29936534
NSC 759852 Vorinostat (USAN) 0.00170676579199122 0.081844953
NSC 107043 Null 0.00170676579199123 0.16445508
NSC 132791 Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo 0.00170676579199123 0.17458168
NSC 618770 Piperidin-4-ol, N-ethyl-N-methyl-3-(1-oxo-3-phenyl-2-propen-1-yl)-4-(2-phenylethen-1-yl)-, (E,E)-, bromide 0.00170676579199123 0.40130285
Total:140  Current:6    [First] [Prev] [Next] [Last]